How many institutions held KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in Q2 2023?

9 institutional investors reported KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares for Q2 2023. Use the holders table for investor-level position and value details.

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)

Q: What does CUSIP 48669G105 represent in this 13F holders report?

CUSIP 48669G105 is the security identifier for KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares used to aggregate holder disclosures.

CUSIP: 48669G105

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / American Depositary Shares
Total 13F shares: 284,444
Total 13F value: $327,598
Share change: +9,655
SEC-reported price per share: $1.16
Number of holders: 9
Value change: +$11,438
Number of buys: 2
Number of sells: 1
Shares outstanding: 11,933,719

Security key

48669G105

Report period

Q2 2023

Institutions

Top holders

KZIA full security history Ownership snapshot Full 13F holder table KAZIA THERAPEUTICS LTD SEC filings KAZIA THERAPEUTICS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

8/8

Latest evidence

31 Mar 2023

13F Lead comparable stake: 1.7% Showing 1-6 of 8 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 1.7%.

8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 1.7%

ACADIAN ASSET MANAGEMENT LLC 0.57%

Belpointe Asset Management LLC 0.03%

NewEdge Advisors, LLC 0%

BANK OF AMERICA CORP /DE/ 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 8 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	1.7%	$205,453 199,450 shares	—	31 Mar 2023
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	0.57%	$70,000 68,224 shares	—	31 Mar 2023
Belpointe Asset Management LLC	13F Company 13F	0.03%	$3,090 3,000 shares	—	31 Mar 2023
NewEdge Advisors, LLC	13F Company 13F	0%	$515 500 shares	—	31 Mar 2023
BANK OF AMERICA CORP /DE/	13F Company 13F	0%	$206 200 shares	—	31 Mar 2023
Allworth Financial LP	13F Company 13F	0%	$90 87 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

284,444

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %